Big Gain For Lineage Cell Therapeutics, Inc.
Tue, Apr 06, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) shot up at $6.07, representing a gain of 30%. The stock appeared on our News Catalysts scanner on Thu, Apr 01, 2021 at 09:59 AM in the 'MERGER' category. From Mon, Mar 22, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Tue, Mar 16, 2021 at $10.28 with a volume of 3M+.
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- ENNV (ENNV:NASDAQ), 2641.03%
- RMO (RMO:NYSE), 59.6%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 35.27%
- SJ (SJ:NASDAQ), 30.38%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 29.98%
- GBOX (GBOX:NASDAQ), 28.55%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 27.43%
- Target Hospitality Corp. (TH:NASDAQ), 24.23%
- FreightCar America, Inc. (RAIL:NASDAQ), 22.87%
- BBQ Holdings, Inc. (BBQ:NASDAQ), 22.38%